Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anticancer adjuvant composition containing RIP3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting RIP3 expression, and method for monitoring sensitivity of anticancer drug

US Patent 10391115 · Granted Aug 27, 2019

Assignee

Inventors

View full patent text on Google Patents →